COVID-19 vaccine tracker and landscape. (2022, April 22). https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948

Gavi, the Vaccine Alliance. (2021, November 25). Around the world, there are now 132 COVID-19 vaccine candidates undergoing clinical trials and 194 candidates in pre-clinical development. Read our latest #COVID19 vaccine race update: Https://t.co/ETtHP6XmYI [Tweet]. @gavi. https://twitter.com/gavi/status/1463953132120010753

Corbevax: All About India’s First Protein Sub-Unit Covid Vaccine to be Given to 12-14 Age Group From Today. (2022, March 16). News18. https://www.news18.com/news/india/corbevax-all-about-indias-first-protein-sub-unit-covid-vaccine-to-be-given-to-12-14-age-group-from-today-4874345.html

Ali Ellebedy. (2021, December 30). We need those who are adept at #SciComm to explain that “Omicron” is sufficiently different from the original strain that was used to make the vaccine. Therefore, the definition of “fully vaccinated” will have to be updated, but that does not mean that the vaccines have failed. [Tweet]. @TheBcellArtist. https://twitter.com/TheBcellArtist/status/1476649138691444740

Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005

Devlin, H., & correspondent, H. D. S. (2022, February 3). Novavax Covid vaccine approved for use in over-18s in UK. The Guardian. https://www.theguardian.com/society/2022/feb/03/novavax-covid-vaccine-approved-for-use-in-over-18s-in-uk

Eric Topol. (2020, November 28). This will go down in history as one of science and medical research’s greatest achievements. Perhaps the most impressive. I put together a preliminary timeline of some key milestones to show how several years of work were compressed into months. Https://t.co/BPcaZwDFkl [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1332771238771630080

Mallapaty, S., Callaway, E., Kozlov, M., Ledford, H., Pickrell, J., & Van Noorden, R. (2021). How COVID vaccines shaped 2021 in eight powerful charts. Nature. https://doi.org/10.1038/d41586-021-03686-x

Devlin, H., & Kollewe, J. (2021, November 26). BioNTech says it could tweak Covid vaccine in 100 days if needed. The Guardian. https://www.theguardian.com/society/2021/nov/26/biontech-says-it-could-tweak-covid-vaccine-in-100-days-if-needed

Reardon, S. (2021). Cuba’s bet on home-grown COVID vaccines is paying off. Nature. https://doi.org/10.1038/d41586-021-03470-x

Couzin-Frankel, J. (2021). Antiviral pills could change pandemic’s course. Science, 374(6569), 799–800. https://doi.org/10.1126/science.acx9605

Mallapaty, S. (2021). The search for people who never get COVID. Nature. https://doi.org/10.1038/d41586-021-02978-6

Zotero doesn't work on this site

Abbas-Hanif, A., Modi, N., Smith, S. K., & Majeed, A. (2021). Covid-19 treatments and vaccines must be evaluated in pregnancy. BMJ, n2377. https://doi.org/10.1136/bmj.n2377

The COVID-19 vaccine race | Gavi, the Vaccine Alliance. (n.d.). Retrieved October 8, 2021, from https://www.gavi.org/vaccineswork/covid-19-vaccine-race

tagesschau.de. (n.d.). Entwicklung von Impfstoffen: Komplett verdrehte Aussage. tagesschau.de. Retrieved March 2, 2021, from https://www.tagesschau.de/faktenfinder/merck-impfstoff-immunitaet-105.html

Ortiz, J. R., & Neuzil, K. M. (2019). Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines. The Journal of Infectious Diseases, 219(Supplement_1), S97–S106. https://doi.org/10.1093/infdis/jiz024

Thorpe, A., Fagerlin, A., Butler, J., Stevens, V., Drews, F. A., Shoemaker, H., Riddoch, M., & Scherer, L. D. (2021). Communicating about COVID-19 vaccine development and safety [Preprint]. Public and Global Health. https://doi.org/10.1101/2021.06.25.21259519

Jørgensen, Frederik Juhl, Alexander Bor, and Michael Bang Petersen. ‘How the Development, Features and Roll-Out of a SARS-COV-2 Vaccine Shape Public Acceptance: A Conjoint Experiment in a Large Representative Sample of Danes’. PsyArXiv, 28 June 2021. https://doi.org/10.31234/osf.io/4y8ap.

Rella, S. A., Kulikova, Y. A., Dermitzakis, E. T., & Kondrashov, F. A. (2021). Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains. Scientific Reports, 11(1), 15729. https://doi.org/10.1038/s41598-021-95025-3

EC AV PORTAL. (n.d.). Retrieved 29 July 2021, from https://audiovisual.ec.europa.eu/en/video/I-202865

Subbaraman, N. (2021). This COVID-vaccine designer is tackling vaccine hesitancy—In churches and on Twitter. Nature, 590(7846), 377–377. https://doi.org/10.1038/d41586-021-00338-y

Mahase, E. (2021). Covid-19: Where are we on vaccines and variants? BMJ, n597. https://doi.org/10.1136/bmj.n597

Nandi, A., Kumar, S., Shet, A., Bloom, D. E., & Laxminarayan, R. (2020). Childhood vaccinations and adult schooling attainment: Long-term evidence from India’s Universal Immunization Programme. Social Science & Medicine (1982), 250, 112885. https://doi.org/10.1016/j.socscimed.2020.112885

Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine, 1–7. https://doi.org/10.1038/s41591-021-01377-8

It’s bizarre that this needs saying, but of course the UK had a Herd Immunity plan—Lessons From The Crisis. (n.d.). Retrieved May 28, 2021, from https://lessonsfromthecrisis.substack.com/p/its-bizarre-that-this-needs-saying

Optimising covid-19 vaccine uptake—Time for a more nuanced approach. (2021, April 30). The BMJ. https://blogs.bmj.com/bmj/2021/04/30/optimising-covid-19-vaccine-uptake-time-for-a-more-nuanced-approach/

Chen, I.-H., Ahorsu, D. K., Ko, N.-Y., Yen, C.-F., Lin, C.-Y., Griffiths, M., & Pakpour, A. (2021). The development and validation of the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students. PsyArXiv. https://doi.org/10.31234/osf.io/abfp6

Initiative, T. D. (2020). SARS-CoV-2 Vaccine Development & Implementation; Scenarios, Options, Key Decisions. https://rs-delve.github.io/reports/2020/10/01/covid19-vaccination-report.html

Dodd, R. H., Pickles, K., Nickel, B., Cvejic, E., Ayre, J., Batcup, C., Bonner, C., Copp, T., Cornell, S., Dakin, T., Isautier, J., & McCaffery, K. J. (2020). Concerns and motivations about COVID-19 vaccination. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30926-9

Graham, B. S. (2020). Rapid COVID-19 vaccine development. Science, 368(6494), 945–946. https://doi.org/10.1126/science.abb8923

Pimenta, Dominic, Christian Yates, Christina Pagel, and Deepti Gurdasani. ‘Delaying the Second Dose of Covid-19 Vaccines’. BMJ 372 (18 March 2021): n710. https://doi.org/10.1136/bmj.n710.

the Guardian. ‘Small Number of Facebook Users Responsible for Most Covid Vaccine Skepticism – Report’, 16 March 2021. http://www.theguardian.com/technology/2021/mar/15/facebook-study-covid-vaccine-skepticism.

NW, 1615 L. St, Suite 800Washington, and DC 20036USA202-419-4300 | Main202-857-8562 | Fax202-419-4372 | Media Inquiries. ‘Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases’. Pew Research Center Science & Society (blog), 3 December 2020. https://www.pewresearch.org/science/2020/12/03/intent-to-get-a-covid-19-vaccine-rises-to-60-as-confidence-in-research-and-development-process-increases/.

Andrew💙Croxford. (2020, December 3). NEW THREAD: possible development of anti-Syncytin responses after immunization with the SARS-CoV-2 spike protein-coding mRNA vaccines, based on a ‘homologous’ region shared between these proteins. [Tweet]. @andrew_croxford. https://twitter.com/andrew_croxford/status/1334593606196187136

Study shows vaccine nationalism could cost rich countries US$4.5 trillion. (2021, January 25). ICC - International Chamber of Commerce. https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/

Cormier, Z. (n.d.). The Second-Generation COVID Vaccines Are Coming. Scientific American. Retrieved 11 February 2021, from https://www.scientificamerican.com/article/the-second-generation-covid-vaccines-are-coming/

Network, T. O. F. (2021, February 8). The Haves and Have-Nots: The geopolitical dilemma of COVID vaccine equity. The OECD Forum Network. http://www.oecd-forum.org/posts/the-haves-and-have-nots-the-geopolitical-dilemma-of-covid-vaccine-equity

Zhang, S. (2020, November 10). The Lame-Duck Vaccine. The Atlantic. https://www.theatlantic.com/health/archive/2020/11/bidens-vaccine-reset/617059/

Natalie E. Dean en Twitter: “VACCINE EFFICACY 101: A biostatistician's primer. Ten tweets to cover:- How is vaccine efficacy calculated?- Distinguishing between infection, disease, & severe disease.- Measuring reduced infectiousness.- Vaccine efficacy vs. effectiveness!n” / Twitter. (n.d.). Twitter. Retrieved September 30, 2020, from https://twitter.com/nataliexdean/status/1310613702476017666

Over 250,000 volunteers now registered for new COVID-19 vaccine trials as recruitment begins for Novavax study. (n.d.). Retrieved September 28, 2020, from https://www.nihr.ac.uk/news/over-250000-volunteers-now-registered-for-new-covid-19-vaccine-trials-as-recruitment-begins-for-novavax-study/25731

magazine, D. C., Smriti Mallapaty,Nature. (n.d.). Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency. Scientific American. Retrieved September 16, 2020, from https://www.scientificamerican.com/article/coronavirus-vaccine-u-k-trial-restarts-but-scientists-question-lack-of-transparency/

Diseases, T. L. I. (2020). Curing COVID-19. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30706-4

Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045

Barber, C. (n.d.). ‘Instant Coffee’ COVID-19 Tests Could Be the Answer to Reopening the U.S. Scientific American. Retrieved August 27, 2020, from https://www.scientificamerican.com/article/instant-coffee-covid-19-tests-could-be-the-answer-to-reopening-the-u-s/

Marshall, M. (n.d.). Everything you need to know about Russia’s coronavirus vaccine claims. New Scientist. Retrieved August 18, 2020, from https://www.newscientist.com/article/2251722-everything-you-need-to-know-about-russias-coronavirus-vaccine-claims/

Lo, A. W., Siah, K. W., & Wong, C. H. (2020). Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs (Working Paper No. 27176; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27176

A Vaccine Reality Check. (n.d.). MSN. Retrieved August 9, 2020, from https://www.msn.com/en-us/news/us/a-vaccine-reality-check/ar-BB178Yaf

CNN, J. G., Naomi Thomas, Dana Vigue and Jacqueline Howard. (n.d.). Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest. CNN. Retrieved August 2, 2020, from https://www.cnn.com/2020/07/20/health/oxford-covid-19-vaccine-results-cansino-pfizer-study/index.html

Younes, G. A., Ayoubi, C., Ballester, O., Cristelli, G., de Rassenfosse, G., Foray, D., Gaule, P., Pellegrino, G., van den Heuvel, M., Webster, B., & Zhou, L. (2020). COVID-19_Insights from Innovation Economists [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/b5zae

Younes, G. A., Ayoubi, C., Ballester, O., Cristelli, G., de Rassenfosse, G., Foray, D., Gaule, P., van den Heuvel, M., Webster, B., & Zhou, L. (2020). COVID-19: Insights from Innovation Economists (with French executive summary) [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/65pgr

Sehgal, D. (2020). Analysis of Vaccines to tackle COVID-19 with Patent Review [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/q96wj

Herper, M. (2020, July 1). Covid-19 vaccine from Pfizer and BioNTech shows positive results. CNBC. https://www.cnbc.com/2020/07/01/coronavirus-vaccine-from-pfizer-and-biontech-shows-positive-results-report-says.html

A COVID-19 vaccine has passed its first human trial. But is it the frontrunner? (2020, May 29). Science. https://www.nationalgeographic.com/science/2020/05/coronavirus-vaccine-passes-first-human-trial-but-is-it-frontrunner-cvd/

Richards, A. D. (2020). Ethical Guidelines for Deliberately Infecting Volunteers with COVID-19 [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/jb7gq

Corbett, K. S., Edwards, D., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness. BioRxiv, 2020.06.11.145920. https://doi.org/10.1101/2020.06.11.145920

Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., Hagglof, T., Oliveira, T. Y., Viant, C., Hurley, A., Hoffmann, H.-H., Millard, K. G., Kost, R. G., Cipolla, M., Gordon, K., … Nussenzweig, M. C. (2020). Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals [Preprint]. Immunology. https://doi.org/10.1101/2020.05.13.092619

Matthews, D. (2020, May 20). How exposing healthy volunteers to Covid-19 for vaccine testing would work. Vox. https://www.vox.com/future-perfect/2020/5/20/21258725/covid-19-human-challenge-trials-vaccine-update-sars-cov-2

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., Marrama, D., de Silva, A. M., Frazier, A., Carlin, A., Greenbaum, J. A., Peters, B., Krammer, F., Smith, D. M., Crotty, S., & Sette, A. (2020). Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, S0092867420306103. https://doi.org/10.1016/j.cell.2020.05.015

EU boosts efforts to adjust R&D programmes to virus crisis. (n.d.). Science|Business. Retrieved April 15, 2020, from https://sciencebusiness.net/news/eu-boosts-efforts-adjust-rd-programmes-virus-crisis